CCL3 and lung carcinoma: To determine if PBMCs from stage I lung cancer patients have higher expression levels of CCL3, IL8 and IL1β than patients without lung cancer, the RT-qPCR results from the preoperative PBMC samples from the stage I lung cancer (n = 62) and control cohorts (n = 32) were compared.